Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Other Working Capital Changes (2016 - 2025)

Angiodynamics (ANGO) has disclosed Other Working Capital Changes for 16 consecutive years, with -$3.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 322.77% year-over-year to -$3.2 million, compared with a TTM value of -$866000.0 through Nov 2025, down 112.95%, and an annual FY2025 reading of -$3.1 million, down 126.64% over the prior year.
  • Other Working Capital Changes was -$3.2 million for Q4 2025 at Angiodynamics, down from $5.5 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $9.4 million in Q1 2025 and bottomed at -$12.5 million in Q2 2025.
  • Average Other Working Capital Changes over 5 years is $616900.0, with a median of $833000.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes soared 656.35% in 2024, then tumbled 411.52% in 2025.
  • Year by year, Other Working Capital Changes stood at $830000.0 in 2021, then plummeted by 317.11% to -$1.8 million in 2022, then surged by 145.01% to $811000.0 in 2023, then plummeted by 194.2% to -$764000.0 in 2024, then crashed by 322.77% to -$3.2 million in 2025.
  • Business Quant data shows Other Working Capital Changes for ANGO at -$3.2 million in Q4 2025, $5.5 million in Q3 2025, and -$12.5 million in Q2 2025.